Affinity Asset Advisors, LLC

Source: SEC Form 13F · as of Mar 2026

Affinity Asset Advisors, LLC holds 89 biotech & pharma companies tracked by BioSniper, totaling $1.69B in value as of Mar 2026 (SEC Form 13F).

Companies held

89

Total value held

$1.69B

CompanySharesValue
APGEApogee Therapeutics, Inc.1,284,926$108.2M
XENEXenon Pharmaceuticals Inc.1,675,000$97.4M
ERASErasca, Inc.5,350,000$86.6M
INSMINSMED Inc480,000$78.5M
ROIVRoivant Sciences Ltd.2,800,000$77.6M
SYRESpyre Therapeutics, Inc.1,279,134$64.5M
CNTACentessa Pharmaceuticals plc1,400,000$55.6M
PRAXPraxis Precision Medicines, Inc.170,000$54.8M
ANABANAPTYSBIO, INC940,000$52.1M
ALKSAlkermes plc.1,350,000$47.7M
CYTKCYTOKINETICS INC700,483$46.2M
ABVXAbivax SA405,000$45.1M
TEVATeva Pharmaceutical Industries Limited1,400,000$42.2M
ACLXArcellx, Inc.362,764$41.7M
MRNAModerna, Inc.800,000$40.6M
DNTHDianthus Therapeutics, Inc. /DE/400,000$33.6M
NUVLNuvalent, Inc.300,000$30.7M
TERNTerns Pharmaceuticals, Inc.562,631$29.7M
COGTCogent Biosciences, Inc.750,000$28.9M
MDGLMADRIGAL PHARMACEUTICALS, INC.55,000$28.8M
STROSUTRO BIOPHARMA, INC.1,069,519$26.6M
FBRXForte Biosciences, Inc.1,011,890$26.2M
ORKAOruka Therapeutics, Inc.499,673$24.5M
TRVITrevi Therapeutics, Inc.2,000,172$23.9M
OVIDOvid Therapeutics Inc.10,636,318$23.6M
ELVNEnliven Therapeutics, Inc.586,904$23.0M
MLYSMineralys Therapeutics, Inc.750,000$20.3M
AVTXAvalo Therapeutics, Inc.1,340,840$20.0M
RVMDREVOLUTION MEDICINES, INC.200,000$19.4M
BMYBRISTOL MYERS SQUIBB CO300,000$18.2M
PTGXProtagonist Therapeutics, Inc172,125$18.1M
CLDXCelldex Therapeutics, Inc.500,000$15.9M
ZURAZura Bio Ltd2,564,303$15.3M
NRIXNurix Therapeutics, Inc.967,620$15.0M
SVRASavara Inc2,512,153$13.7M
CATXPerspective Therapeutics, Inc.3,164,582$13.2M
ARWRARROWHEAD PHARMACEUTICALS, INC.200,000$12.5M
DMRADamora Therapeutics, Inc.450,000$11.7M
EPRXEUPRAXIA PHARMACEUTICALS INC.1,589,005$11.5M
ANROAlto Neuroscience, Inc.500,000$11.2M
BBIOBridgeBio Pharma, Inc.150,000$11.1M
CGEMCullinan Therapeutics, Inc.781,260$11.1M
BLTEBELITE BIO, INC65,000$10.4M
WVEWave Life Sciences Ltd.1,401,727$10.2M
VERAVera Therapeutics, Inc.250,000$10.1M
TYRATyra Biosciences, Inc.257,512$9.9M
IBRXImmunityBio, Inc.1,250,000$9.6M
JBIOJade Biosciences, Inc.639,956$9.0M
TVTXTravere Therapeutics, Inc.300,000$8.9M
NAMSNEWAMSTERDAM PHARMA CO N.V.275,000$8.8M
KRROKorro Bio, Inc.706,904$8.0M
CRSPCRISPR Therapeutics AG150,000$7.1M
SGPSpyGlass Pharma Inc.250,000$6.5M
NVONovo Nordisk A/S175,000$6.4M
CMPSCOMPASS Pathways plc1,108,483$6.1M
IBIOiBio, Inc.3,107,200$5.9M
QUREuniQure N.V.300,000$4.9M
VRDNViridian Therapeutics, Inc.\DE250,000$4.9M
CLYMClimb Bio, Inc.700,000$4.8M
RZLTRezolute, Inc.1,547,641$4.7M
SGMTSagimet Biosciences Inc.868,020$4.5M
MBXMBX Biosciences, Inc.150,000$4.5M
TSHATaysha Gene Therapies, Inc.1,000,000$4.5M
MANEVeradermics Incorporated70,000$4.4M
GENBGenerate Biomedicines Inc.350,000$4.4M
CGONCG Oncology, Inc.60,000$4.1M
AVBPArriVent BioPharma, Inc.175,000$4.0M
RLAYRelay Therapeutics, Inc.400,000$4.0M
PRQRProQR Therapeutics N.V.2,454,278$4.0M
VRCAVerrica Pharmaceuticals Inc.707,338$3.7M
DTILPRECISION BIOSCIENCES INC597,946$3.3M
KPTIKaryopharm Therapeutics Inc.500,000$2.8M
SLGLSol-Gel Technologies Ltd.35,000$2.8M
CRNXCrinetics Pharmaceuticals, Inc.75,000$2.7M
NXTCNextCure, Inc.241,826$2.6M
IMVTImmunovant, Inc.100,000$2.5M
EQEquillium, Inc.1,226,310$2.5M
SABSSAB BIOTHERAPEUTICS, INC.575,000$2.2M
CORTCORCEPT THERAPEUTICS INC50,000$2.0M
OBIOOrchestra BioMed Holdings Inc.402,550$1.7M
KZRKezar Life Sciences, Inc.229,076$1.7M
MGNXMACROGENICS INC500,000$1.4M
ANLAdlai Nortye Ltd.164,748$1.1M
ALECAlector, Inc.500,000$1.1M
OKUROnKure Therapeutics, Inc.240,963$998K
LENZLENZ Therapeutics, Inc.100,000$915K
XFORX4 Pharmaceuticals, Inc145,000$599K
QTTBQ32 Bio Inc.27,777$178K
ADGMAdagio Medical Holdings Inc80,000$92K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Affinity Asset Advisors, LLC — Biotech 13F Holdings & Portfolio | BioSniper